Issue 2/2017
Content (6 Articles)
Lymphoma (JW Sweetenham, Section Editor)
Molecular Subtyping in Diffuse Large B Cell Lymphoma: Closer to an Approach of Precision Therapy
Reem Karmali, Leo I. Gordon
Lymphoma (JW Sweetenham, Section Editor)
What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
Benjamin N. Voorhies, Deborah M. Stephens
Lymphoma (JW Sweetenham, Section Editor)
Surveillance Scans in Lymphoma: Friend or Foe?
Tycel Phillips, Jessica Mercer
Lower Gastrointestinal Cancers (AB Benson, Section Editor)
Defining the Optimal Use of Ablation for Metastatic Colorectal Cancer to the Liver Without High-Level Evidence
Rafael Diaz-Nieto, Stephen Fenwick, Hassan Malik, Graeme Poston
Lower Gastrointestinal Cancers (AB Benson, Section Editor)
BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?
Romain Cohen, Pascale Cervera, Magali Svrcek, Anna Pellat, Chantal Dreyer, Aimery de Gramont, Thierry André
Lower Gastrointestinal Cancers (AB Benson, Section Editor)
Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design
Nitesh Rana, A. Bapsi Chakravarthy, Lisa A. Kachnic